What the FDA labels say about taking them together
Bromocriptine and lanreotide
Lanreotide's FDA label of October 11, 2024 names bromocriptine in its drug interactions section; the bromocriptine labels PlainMeds reads (2) do not name lanreotide. The lanreotide label: “Dosage adjustment of cyclosporine may be needed. Bromocriptine: SOMATULINE DEPOT may increase the absorption of bromocriptine. Bradycardia-Inducing Drugs (e.g., beta-blockers):”
Check it at the source: the bromocriptine FDA label on DailyMed (effective July 27, 2026, ANI Pharmaceuticals, Inc.); the lanreotide FDA label on DailyMed (effective October 11, 2024, Ipsen Biopharmaceuticals, Inc.).
What does the bromocriptine label say about lanreotide?
Bromocriptine's label (effective July 27, 2026) and its 1 other brand-application label do not name lanreotide in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Bromocriptine Mesylate), ANI Pharmaceuticals, Inc., effective July 27, 2026 (SPL set 17f3a343-1782-4799-95ba-31dfe93be2cf), via openFDA; the full label on DailyMed
What does the lanreotide label say about bromocriptine?
Lanreotide label, drug interactionsDosage adjustment of cyclosporine may be needed. ( 7.2 ) Bromocriptine: SOMATULINE DEPOT may increase the absorption of bromocriptine. ( 7.3 ) Bradycardia-Inducing Drugs (e.g., beta-blockers):
Source: FDA drug label (Lanreotide Acetate, NDA215395), Cipla USA Inc., effective September 1, 2024 (SPL set 11da176a-99bc-4ada-8b3f-6bd2b37a6313), via openFDA
Source: FDA drug label (SOMATULINE DEPOT), Ipsen Biopharmaceuticals, Inc., effective October 11, 2024 (SPL set 6e4a41fd-a753-4362-87ee-8cc56ed3660d), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Bromocriptine | Lanreotide | |
|---|---|---|
| Labeled for | Parkinson's disease, Type 2 diabetes | n/a |
| Boxed warning | No | No |
| Pharmacy cost (NADAC) | $1.61 per tablet 2.5 mg tablet | n/a |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once